Proton

Varian Announces New Addition to FlashForward Consortium

Monday, May 18, 2020 - 1:15pm

Now including 20 members, representing nine countries, the Consortiumis focused on preclinical research, clinical implementation, and advocacy efforts of FLASH therapy.

Key Points: 
  • Now including 20 members, representing nine countries, the Consortiumis focused on preclinical research, clinical implementation, and advocacy efforts of FLASH therapy.
  • Varian is installing a Varian ProBeam Compact system equipped with a 360-degree gantry and integrated cone beam CT at Proton Therapy Pte., Ltd.'s site in Singapore.
  • "We are proud to welcome Proton Therapy Pte., Ltd. to the FlashForward Consortium," said Kolleen Kennedy, chief growth officer and president of Proton Therapy Solutions, Varian.
  • "Representing our first member from Southeast Asia, they are a significant new addition to the Consortium.

Hitachi's First Proton Therapy System in Europe Opens at Clinica Universidad de Navarra in Spain

Friday, May 8, 2020 - 2:22am

Clinica Universidad de Navarra is the first hospital which Hitachi has delivered the whole proton therapy system in Europe.

Key Points: 
  • Clinica Universidad de Navarra is the first hospital which Hitachi has delivered the whole proton therapy system in Europe.
  • The proton therapy system installed at Clinica Universidad de Navarra is equipped with state-of-the-art technology including spot scanning technology that sends a therapeutic proton beam precisely conforming to the shape of the target tumor.
  • And it has a 360degree rotating gantry treatment room with cone beam CT(1) and Real-time image Gated Proton Therapy (RGPT)(2) capability.
  • Clinica Universidad de Navarra, based in Navarra and Madrid, Spain, is a world-class private hospital focusing on medical research, education and clinical care.

MEVION S250i Proton Therapy System Receives Approval from Health Canada

Thursday, April 23, 2020 - 11:30am

Mevion Medical Systems announced today that the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) has received a Medical Device License from Health Canada, opening the door for commercial sales in Canada.

Key Points: 
  • Mevion Medical Systems announced today that the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) has received a Medical Device License from Health Canada, opening the door for commercial sales in Canada.
  • The MEVION S250i is the only proton therapy system approved for use in Canada.
  • Mevion was the first company to innovate this new approach to proton therapy and have more systems installed and treating patients than any other compact proton therapy manufacturer in the US.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

Danbury Proton Selects Mevion To Equip New Treatment Center

Tuesday, April 21, 2020 - 11:30am

Mevion Medical Systems announced today that it has signed an agreement with Danbury Proton to purchase the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to equip their new center in Danbury, CT. Danbury Proton has recently published a notice of intent to submit a Certificate of Need (CON) to the Connecticut State Office of Health Strategy for a new state-of-the-art center that is slated to employ over 30 full-time employees.

Key Points: 
  • Mevion Medical Systems announced today that it has signed an agreement with Danbury Proton to purchase the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to equip their new center in Danbury, CT. Danbury Proton has recently published a notice of intent to submit a Certificate of Need (CON) to the Connecticut State Office of Health Strategy for a new state-of-the-art center that is slated to employ over 30 full-time employees.
  • View the full release here: https://www.businesswire.com/news/home/20200421005152/en/
    Rendering of the future Danbury Proton center.
  • (Photo: Business Wire)
    The MEVION S250i with HYPERSCAN was the logical choice to equip our new center, said Stephen Courtney, managing director of Danbury Proton.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

American Shared Hospital Services Reports Fourth Quarter and Year End 2019 Results

Thursday, April 2, 2020 - 1:03pm

San Francisco, CA, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and twelve months ended December 31, 2019.

Key Points: 
  • San Francisco, CA, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the fourth quarter and twelve months ended December 31, 2019.
  • Total proton therapy fractions in the fourth quarter increased 4.3% quarter over quarter.
  • Adjusted EBITDA, a non-GAAP financial measure, was $2,056,000 for the fourth quarter of 2019, compared to $2,346,000 for the fourth quarter of 2018.
  • About American Shared Hospital Services (NYSE American: AMS)
    American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services.

Synchrocyclotron for the MEVION S250i Proton Therapy System Delivered to Huntsman Cancer Institute

Wednesday, April 1, 2020 - 2:00pm

Mevion Medical Systems announced today that it has delivered the synchrocyclotron accelerator for the MEVION S250i Proton Therapy System to Huntsman Cancer Institute (HCI) at the University of Utah (U of U) on March 28, 2020.

Key Points: 
  • Mevion Medical Systems announced today that it has delivered the synchrocyclotron accelerator for the MEVION S250i Proton Therapy System to Huntsman Cancer Institute (HCI) at the University of Utah (U of U) on March 28, 2020.
  • By reducing the size and complexity of a proton therapy system, Mevion has allowed hospitals to offer proton therapy without the enormous expenditures and space requirements needed by other single-room or multi-room proton systems.
  • Today, more cancer centers are considering providing compact proton therapy to their patients because of the technology Mevion has advanced.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

Varian Brings Machine Learning to Proton Treatment Planning with Eclipse v16

Tuesday, March 31, 2020 - 1:15pm

Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technologies like machine learning, Varian (NYSE: VAR), today announced the newest release of its treatment planning system, Eclipse v16.

Key Points: 
  • Driven by its Intelligent Cancer Care approach in developing new solutions that use advanced technologies like machine learning, Varian (NYSE: VAR), today announced the newest release of its treatment planning system, Eclipse v16.
  • This knowledge-based planning software is now available for proton treatment planning with RapidPlan PT.
  • Varian is the first vendor in the industry to offer machine learning capability in both proton and photon treatment planning.
  • "With the number of operational proton treatment rooms continuing to increase, there is a need for experienced proton therapy clinicians," said Kolleen Kennedy, chief growth officer, president, Proton Solutions, Varian.

Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam

Tuesday, March 17, 2020 - 12:15pm

PALO ALTO, Calif., March 17, 2020 /PRNewswire/ --Varian (NYSE: VAR) announced today,Proton International at UAB has now treated its first cancer patient with the Varian ProBeam Compact proton therapy system.

Key Points: 
  • PALO ALTO, Calif., March 17, 2020 /PRNewswire/ --Varian (NYSE: VAR) announced today,Proton International at UAB has now treated its first cancer patient with the Varian ProBeam Compact proton therapy system.
  • The center, a collaboration between The University of Alabama at Birmingham (UAB) and Proton International, opened in January 2020 and is the first proton therapy center in Alabama and one of only 35 proton therapy centers in the United States.
  • "The Varian ProBeam system is one of the most advanced tools available and our physicians are now able to improve care and precision of treatment for their cancer patients.
  • The Varian ProBeam Compact system is the only clinical single room system capable of fully rotational intensity modulated proton therapy (IMPT).

Mevion Medical Systems Appoints Curt Kienast as Chief Operating Officer

Monday, February 17, 2020 - 2:00pm

Mevion Medical Systems, the leader in compact proton therapy, today announced the appointment of Curt Kienast to chief operating officer of the organization, effective immediately.

Key Points: 
  • Mevion Medical Systems, the leader in compact proton therapy, today announced the appointment of Curt Kienast to chief operating officer of the organization, effective immediately.
  • View the full release here: https://www.businesswire.com/news/home/20200217005049/en/
    I am very proud to announce the promotion of Curt to chief operating officer, said Tina Yu, chief executive officer of Mevion Medical Systems.
  • I am honored and excited for the opportunity to lead Mevions team in a greater capacity, said Curt Kienast.
  • Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients.

MEVION S250i Selected by Jinshazhou Hospital to Equip New Proton Therapy Center in Guangzhou, China

Thursday, January 16, 2020 - 2:00pm

The International Cancer Center is a joint effort between Jinshazhou Hospital and the ICON Group , Australias leading cancer care service provider.

Key Points: 
  • The International Cancer Center is a joint effort between Jinshazhou Hospital and the ICON Group , Australias leading cancer care service provider.
  • We are pleased to be partnering with Mevion to make proton therapy available to benefit cancer patients in South China, said Wensheng Liu, President of Jinshazhou Hospital.
  • MEVION S250i system is the most advanced proton therapy system available today and represents the best overall proton therapy solution.
  • Mevion pioneered the worlds first compact single-room proton therapy system, said Lawrence Yuan Tian, Ph.D., Chairman of Mevion Medical Systems.